Follow
Abera Bioscience AB
Spotlight (Sweden)
Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed and patented platform. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and oncology. The business is located around the Nordic market. The company was founded in 2012 and is headquartered in Solna.
Sector:
HEALTH CARE
Current instruments
News
Nothing to display for this company
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
ABERA
SE0015245097
Spotlight
Sweden (SE)
Details of share in Abera Bioscience AB with ticker ABERA
Status
Active
Order book id
7M60
Amount of instruments
10 460 209
Par value
8.0000
Currency
SEK
First trading date
24 Feb 2021
Type
Price
Pre-money valuation
Time
Files
IPO
6.90 SEK
48.09M SEK
19 Jan - 02 Feb 2021
IPO in Abera Bioscience AB
People
Maria Alriksson
CEO
Anders Ericsson
Chairman of the board
Cristina Glad
Board member
Fredrik Juserius
Board member
Joen Luirink
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Svetsarvägen 15
Zip code
171 41
City/district
Solna
Country
Sweden (SE)
Registration number
556909-0904
LEI code
549300IO3Q8IE2FDUS29
First trade date
24 Feb 2021
Registration date
03 Nov 2012
Short name
Abera

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More